{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:39:52Z","timestamp":1793191192659,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"17","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["APP1147430"],"award-info":[{"award-number":["APP1147430"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Dr Havard\u2019s NSW Health Early-Mid Career Fellowship"},{"DOI":"10.13039\/501100001773","name":"UNSW Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AbbVie Australia"},{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NHMRC Investigator"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>We determined the prevalence of prescription smoking cessation pharmacotherapy (SCP) use after hospitalization for major cardiovascular disease (MCD) among people who smoke and whether this varies by sex.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We conducted a population-based cohort study including all people hospitalized in New South Wales, Australia, between July 2013 and December 2018 (2017 for private hospitals) with an MCD diagnosis. For patients who also had a diagnosis of current tobacco use, we used linked pharmaceutical dispensing records to identify prescription SCP dispensings within 90 days post-discharge. We determined the proportion who were dispensed an SCP within 90 days, overall and by type of SCP. We used logistic regression to estimate the odds of females being dispensed an SCP relative to males. Of the 150 758 patients hospitalized for an MCD, 20 162 (13.4%) had a current tobacco use diagnosis, 31% of whom were female. Of these, 11.3% (12.4% of females, 10.9% of males) received prescription SCP within 90 days post-discharge; 3.0% were dispensed varenicline, and 8.3% were dispensed nicotine replacement therapy patches. Females were more likely than males to be dispensed a prescription SCP [odds ratio (OR) 1.16, 95% confidence interval (CI) 1.06\u20131.27)]; however, this was not maintained after adjusting for potential confounders (adjusted OR 1.04, 95% CI 0.94\u20131.15).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Very few females and males who smoke use prescription SCPs after hospitalization for an MCD. The use of varenicline, the SCP with the highest efficacy, was particularly low. This represents a missed opportunity to increase smoking cessation in this high-risk population, thereby reducing their risk of recurrent cardiovascular events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwac172","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T08:03:13Z","timestamp":1660204993000},"page":"2173-2182","source":"Crossref","is-referenced-by-count":8,"title":["Uptake of prescription smoking cessation pharmacotherapies after hospitalization for major cardiovascular disease"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5577-1118","authenticated-orcid":false,"given":"Annelies L","family":"Robijn","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney , 22-42 King Street, Randwick NSW 2031 , Australia"},{"name":"Centre for Big Data Research in Health, UNSW Sydney , Australia Level 2, G27 Botany Street, Kensington NSW 2052 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health, UNSW Sydney , Australia Level 5, 1 King Street, Newtown NSW 2042 , Australia"},{"name":"The George Institute for Global Health, School of Public Health, Imperial College London , 84 Wood Lane, London W12 0BZ , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-6855","authenticated-orcid":false,"given":"Sallie-Anne","family":"Pearson","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, UNSW Sydney , Australia Level 2, G27 Botany Street, Kensington NSW 2052 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjumin","family":"Hsu","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, UNSW Sydney , Australia Level 2, G27 Botany Street, Kensington NSW 2052 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara K","family":"Chow","sequence":"additional","affiliation":[{"name":"Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney , Australia Rm No 2041, Research & Education Network, Westmead Hospital, Westmead NSW 2145 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian B","family":"Filion","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital , 3755 C\u00f4te Ste-Catherine Road, Montreal, Quebec H3T 1E2 , Canada"},{"name":"Department of Medicine McGill University , 1001 Decarie Boulevard, suite D05-2212, Montreal, Quebec H4A 3J1 , Canada"},{"name":"Department of Epidemiology, Biostatistics, and Occupational Health, McGill University , 2001 McGill College, Suite 1200, Montreal, Quebec H3A 1G1 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-661X","authenticated-orcid":false,"given":"Louisa","family":"Jorm","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, UNSW Sydney , Australia Level 2, G27 Botany Street, Kensington NSW 2052 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alys","family":"Havard","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney , 22-42 King Street, Randwick NSW 2031 , Australia"},{"name":"Centre for Big Data Research in Health, UNSW Sydney , Australia Level 2, G27 Botany Street, Kensington NSW 2052 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"2022120714552852200_zwac172-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1351-4","article-title":"Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study","volume":"17","author":"Banks","year":"2019","journal-title":"BMC Med"},{"key":"2022120714552852200_zwac172-B2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2019.03.019","article-title":"Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial disease","volume":"213","author":"van den Berg","year":"2019","journal-title":"Am Heart J"},{"key":"2022120714552852200_zwac172-B3","volume-title":"Smoking cessation. A report of the surgeon general","author":"U.S. Department of Health and Human Services","year":"2020"},{"key":"2022120714552852200_zwac172-B4","first-page":"1","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"2015","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2022120714552852200_zwac172-B5","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1111\/add.15452","article-title":"Supporting smoking cessation and preventing relapse following a stay in a smoke-free setting: a meta-analysis and investigation of effective behaviour change techniques","volume":"116","author":"Shoesmith","year":"2021","journal-title":"Addiction"},{"key":"2022120714552852200_zwac172-B6","first-page":"1","article-title":"Interventions for smoking cessation in hospitalised patients","volume":"2017","author":"Rigotti","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2022120714552852200_zwac172-B7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2022.0395","article-title":"Treatment of tobacco smoking: a review","volume":"327","author":"Rigotti","year":"2022","journal-title":"JAMA"},{"key":"2022120714552852200_zwac172-B8","volume-title":"Supporting smoking cessation: a guide of health professionals","author":"The Royal Australian College of General Practitioners","year":"2019","edition":"2nd ed"},{"key":"2022120714552852200_zwac172-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41533-016-0004-8","article-title":"National guidelines for smoking cessation in primary care: a literature review and evidence analysis","volume":"27","author":"Verbiest","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"key":"2022120714552852200_zwac172-B10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/2047487312460517","article-title":"Smoking cessation interventions following acute coronary syndrome: a missed opportunity?","volume":"21","author":"Boggon","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"2022120714552852200_zwac172-B11","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamacardio.2017.2369","article-title":"Use of prescription smoking cessation medications after myocardial infarction among older patients in community practice","volume":"2","author":"Pagidipati","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2022120714552852200_zwac172-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106012","article-title":"Rates, predictors, and impact of smoking cessation after stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"30","author":"Noubiap","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2022120714552852200_zwac172-B13","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2022.03.377","article-title":"Cigarette smoking, cessation, and risk of heart failure with preserved and reduced ejection fraction","volume":"79","author":"Ding","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2022120714552852200_zwac172-B14","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/heartjnl-2017-311429","article-title":"Sex differences in risk factor management of coronary heart disease across three regions","volume":"103","author":"Zhao","year":"2017","journal-title":"Heart"},{"key":"2022120714552852200_zwac172-B15","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/hrt.2010.196170","article-title":"Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event","volume":"96","author":"Dallongevillle","year":"2010","journal-title":"Heart"},{"key":"2022120714552852200_zwac172-B16","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.3399\/bjgp16X688405","article-title":"Smoking cessation interventions for patients with coronary heart disease and comorbidities: an observational cross-sectional study in primary care","volume":"67","author":"Blane","year":"2017","journal-title":"Br J Gen Pract"},{"key":"2022120714552852200_zwac172-B17","volume-title":"The international statistical classification of diseases and related health problems, tenth revision, Australian modification (ICD-10-AM)","author":"National Centre for Classification in Health","year":"2008","edition":"5th ed"},{"key":"2022120714552852200_zwac172-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17061\/phrp2531532","article-title":"Categorising major cardiovascular disease hospitalisations from routinely collected data","volume":"25","author":"Joshy","year":"2015","journal-title":"Public Health Res Pract"},{"key":"2022120714552852200_zwac172-B19","author":"Australian Government Department of Health"},{"key":"2022120714552852200_zwac172-B20","author":"Australian Government Department of Health"},{"key":"2022120714552852200_zwac172-B21","author":"Australian Government Department of Health"},{"key":"2022120714552852200_zwac172-B22","author":"NSW Ministry of Health","year":"2015"},{"key":"2022120714552852200_zwac172-B23","author":"Australian Government Department of Health","year":"2014"},{"key":"2022120714552852200_zwac172-B24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imj.15036","article-title":"Evidence-practice gaps in P2Y12 inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population-level data linkage in Australia","volume":"52","author":"Falster","year":"2022","journal-title":"Intern Med J"},{"key":"2022120714552852200_zwac172-B25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5694\/mja2.50507","article-title":"Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation","volume":"213","author":"Hsu","year":"2020","journal-title":"Med J Aust"},{"key":"2022120714552852200_zwac172-B26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7861\/clinmed.2020-0359","article-title":"Quality of smoking cessation advice in guidelines of tobacco-related diseases: an updated systematic review","volume":"20","author":"Ekezie","year":"2020","journal-title":"Clin Med"},{"key":"2022120714552852200_zwac172-B27","first-page":"895","article-title":"National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016","volume-title":"Heart Lung Circ","author":"Chew","year":"2016"},{"key":"2022120714552852200_zwac172-B28","first-page":"1","article-title":"Chapter 4. Secondary prevention","author":"Stroke Foundation","year":"2017"},{"key":"2022120714552852200_zwac172-B29","first-page":"1","article-title":"Strategies to improve smoking cessation rates in primary care","volume-title":"Cochrane Database Syst Rev","author":"Lindson","year":"2021"},{"key":"2022120714552852200_zwac172-B30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/add.14953","article-title":"Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial","volume":"115","author":"Carpenter","year":"2020","journal-title":"Addiction"},{"key":"2022120714552852200_zwac172-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCOUTCOMES.115.002458","article-title":"Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials","volume":"10","author":"Suissa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2022120714552852200_zwac172-B32","doi-asserted-by":"crossref","first-page":"e2136372","DOI":"10.1001\/jamanetworkopen.2021.36372","article-title":"Comparison of cardiovascular safety for smoking cessation pharmacotherapies in a population-based cohort in Australia","volume":"4","author":"Havard","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2022120714552852200_zwac172-B33","doi-asserted-by":"crossref","first-page":"e005768","DOI":"10.1136\/bmjopen-2014-005768","article-title":"Variation in the recording of common health conditions in routine hospital data: study using linked survey and administrative data in New South Wales, Australia","volume":"4","author":"Lujic","year":"2014","journal-title":"BMJ Open"},{"key":"2022120714552852200_zwac172-B34","doi-asserted-by":"crossref","first-page":"e95029","DOI":"10.1371\/journal.pone.0095029","article-title":"Risk adjustment for smoking identified through tobacco use diagnoses in hospital data: a validation study","volume":"9","author":"Havard","year":"2014","journal-title":"PLoS ONE"},{"key":"2022120714552852200_zwac172-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/heartasia-2018-011122","article-title":"Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study","volume":"11","author":"Chow","year":"2019","journal-title":"Heart Asia"},{"key":"2022120714552852200_zwac172-B36","first-page":"342","article-title":"Access to subsidized smoking cessation medications by Australian smokers aged 45 years and older: a population-based cohort study","volume":"19","author":"Skinner","year":"2017","journal-title":"Nicotine Tob Res"},{"key":"2022120714552852200_zwac172-B37","volume-title":"Post-market review of medicines for smoking cessation\u2014section 2","author":"Pharmaceutical Benefits Advisory Committee","year":"2021"},{"key":"2022120714552852200_zwac172-B38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1467-842X.2003.tb00820.x","article-title":"Nicotine replacement therapy products over the counter: real-life use in the Australian community","volume":"27","author":"Paul","year":"2003","journal-title":"Aust N Z J Public Health"},{"key":"2022120714552852200_zwac172-B39","author":"Australian Government Department of Health"},{"key":"2022120714552852200_zwac172-B40","author":"Australian Institute of Health and Welfare","year":"2017"},{"key":"2022120714552852200_zwac172-B41","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1177\/2047487320941993","article-title":"Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC)","volume":"28","author":"Kavousi","year":"2021","journal-title":"Eur J Prev Cardiol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwac172\/45498038\/zwac172.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/17\/2173\/47679259\/zwac172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/17\/2173\/47679259\/zwac172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T16:09:55Z","timestamp":1670429395000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/29\/17\/2173\/6660835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":41,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,8,11]]},"published-print":{"date-parts":[[2022,12,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwac172","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,23]]},"published":{"date-parts":[[2022,8,11]]}}}